Alkermes plc (NASDAQ:ALKS): A Fundamentally Weighted Stock for Long-Term Investors
Alkermes plc (NASDAQ:ALKS) shares fell to a low of $24.36 before closing at $24.42. Intraday shares traded counted 2.55 million, which was -55.32% lower than
Alkermes plc (NASDAQ:ALKS) shares fell to a low of $24.36 before closing at $24.42. Intraday shares traded counted 2.55 million, which was -55.32% lower than
Alkermes plc (NASDAQ:ALKS) shares fell to a low of $24.9601 before closing at $25.03. Intraday shares traded counted 1.55 million, which was 3.46% higher than
Alkermes plc (NASDAQ:ALKS) shares fell to a low of $23.17 before closing at $24.48. Intraday shares traded counted 2.18 million, which was -37.67% lower than
Alkermes plc (NASDAQ:ALKS) shares traded higher over the last trading session, gaining 0.65% on 06/02/21. The shares fell to a low of $23.11 before closing
Alkermes Plc [NASDAQ: ALKS] stock rose significantly on Monday after the company’s bipolar and schizophrenia treatment got a positive review in the wake of the
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.